Crossmark

Bridging the clinical trial gap in Saudi Arabia: a multi-stakeholder conference-based consensus on strategic initiatives for global competitiveness and patient inclusion

Crossref DOI link: https://doi.org/10.1007/s44446-026-00099-7

Published Online: 2026-07-21

Published Print: 2026-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al Jeraisy, Majed

Turgonyi, Eva

Misik, Vladimir

Alaskar, Ahmed
Funding

Funding for this research was provided by:

AstraZeneca
License Information

Text and Data Mining valid from 2026-07-21

Version of Record valid from 2026-07-21
More Information

Article History

Received: 5 March 2026

Accepted: 3 June 2026

First Online: 21 July 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Consent for publication: Not applicable.

Competing interests: Authors have no relevant financial or non-financial interest to declare.

Document is current

Any future updates will be listed below